A Systematic Review of Risk Factors for Brain Metastases and Value of Prophylactic Cranial Irradiation in Non-Small Cell Lung Cancer
Authors:
- Dian-Shui SunDSDian-Shui Sun
- Li-Kuan HuLHLi-Kuan Hu
- Ying CaiYCYing Cai
- Xiao-Mei LiXLXiao-Mei Li
- Lan YeLYLan Ye
- Hua-Ying HouHHHua-Ying Hou
- Cui-Hong WangCWCui-Hong Wang
- Yu-Hua JiangYJYu-Hua Jiang
Open Access
- 1 February 2014
- journal article
- research article
- Published by Asian Pacific Organization for Cancer Prevention in Asian Pacific Journal of Cancer Prevention
- Vol. 15 (3) , 1233-1239
Abstract
A Systematic Review of Risk Factors for Brain Metastases and Value of Prophylactic Cranial Irradiation in Non-Small Cell Lung Cancer Meta-analysis;risk factors;brain metastases;prophylactic cranial irradiation;NSCLC; Background: The incidence of brain metastases (BM) varies in patients with non-small cell lung cancer (NSCLC), calls into question the value of prophylactic cranial irradiation (PCI). It is possible that clinicopathologic characteristics are associated with the development of BM, but these have yet to be identified in detail. Thus, we conducted the present meta-analysis on risk factors for BM and the value of PCI in patients with NSCLC. Methods: Eligible data were extracted and the risk factors for BM and the value of PCI in patients with NSCLC were analyzed by calculating the pooled odds ratio (OR). Heterogeneity was detected using Q and I-squared statistics, and publication bias was tested by funnel plots and Egger's test. Results: Six randomized controlled trials with a focus on the value of PCI and 13 eligible studies with a focus on risk factors for BM were included. PCI significantly reduced the incidence of BM in patients with NSCLC (p=0.000, pooled OR=0.34, 95% confidence interval = 0.37-0.59). Compared with non-squamous cell carcinoma, squamous cell carcinoma was associated with a low incidence of BM in patients with NSCLC (p=0.000, pooled OR=0.47, 95% confidence interval =0.34-0.65). The funnel plot and Egger's test suggested that there was no publication bias in the current meta-analysis. Conclusions: This meta-analysis provides statistical evidence that compared with non-squamous cell carcinoma, squamous cell carcinoma can be used as a predictor for BM in patients with NSCLC, and PCI might reduce the incidence of BM in patients with NSCLC, but does not provide a survival benefit.Keywords
This publication has 29 references indexed in Scilit:
- Risk factors of brain metastases in completely resected pathological stage IIIA-N2 non-small cell lung cancerRadiation Oncology, 2012
- Phase III Comparison of Prophylactic Cranial Irradiation Versus Observation in Patients With Locally Advanced Non–Small-Cell Lung Cancer: Primary Analysis of Radiation Therapy Oncology Group Study RTOG 0214Journal of Clinical Oncology, 2011
- Factors associated with the development of brain metastasesCancer, 2010
- Risk of cerebral metastases and neurological death after pathological complete response to neoadjuvant therapy for locally advanced nonsmall‐cell lung cancerCancer, 2007
- Multivariate analysis of factors predictive of brain metastases in localised non-small cell lung carcinomaLung Cancer, 2004
- Brain metastases in locally advanced nonsmall cell lung carcinoma after multimodality treatmentCancer, 2002
- Patterns of relapse of N2 nonsmall-cell lung carcinoma patients treated with preoperative chemotherapyCancer, 2001
- Recursive partitioning analysis (RPA) of prognostic factors in three radiation therapy oncology group (RTOG) brain metastases trialsInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 1997
- Treatment of single brain metastasis: Radiotherapy alone or combined with neurosurgeryAnnals of Neurology, 1993
- A Randomized Trial of Surgery in the Treatment of Single Metastases to the BrainNew England Journal of Medicine, 1990